$359 Million is the total value of Tamarack Advisers, LP's 33 reported holdings in Q2 2020. The portfolio turnover from Q1 2020 to Q2 2020 was 110.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| PCRX | Buy | PACIRA BIOSCIENCES INCequity | $36,729,000 | +99.2% | 700,000 | +27.3% | 10.23% | +46.4% |
| PRGO | Buy | PERRIGO CO PLCequity | $26,253,000 | +36.5% | 475,000 | +18.8% | 7.31% | +0.3% |
| UTHR | Buy | UNITED THERAPEUTICS CORPequity | $21,175,000 | +38.7% | 175,000 | +8.7% | 5.90% | +2.0% |
| ICUI | Buy | ICU MEDICAL INCequity | $14,376,000 | +547.9% | 78,000 | +609.1% | 4.00% | +376.4% |
| LNTH | Buy | LANTHEUS HOLDINGS INCequity | $13,585,000 | +432.3% | 950,000 | +375.0% | 3.78% | +291.5% |
| RIGL | Buy | RIGEL PHARMACEUTICALS INCequity | $12,536,000 | +44.8% | 6,850,000 | +23.4% | 3.49% | +6.4% |
| PHR | Buy | PHREESIA INCequity | $11,312,000 | +115.1% | 400,000 | +60.0% | 3.15% | +58.2% |
| RDNT | Buy | RADNET INCequity | $11,109,000 | +369.7% | 700,000 | +211.1% | 3.09% | +245.2% |
| GWPH | New | GW PHARMACEUTICALS -ADRdepository receipt | $11,045,000 | – | 90,000 | +100.0% | 3.08% | – |
| UNH | New | UNITEDHEALTH GROUP INCequity | $10,323,000 | – | 35,000 | +100.0% | 2.87% | – |
| LH | New | LABORATORY CRP OF AMER HLDGSequity | $9,136,000 | – | 55,000 | +100.0% | 2.54% | – |
| Buy | GLD US 01/15/21 C150call | $8,208,000 | +90.7% | 4,000 | +14.3% | 2.28% | +40.2% | |
| ABT | New | ABBOTT LABORATORIESequity | $6,857,000 | – | 75,000 | +100.0% | 1.91% | – |
| AMRS | New | AMYRIS INCequity | $5,693,000 | – | 1,333,333 | +100.0% | 1.58% | – |
| PLXS | New | PLEXUS CORPequity | $4,657,000 | – | 66,000 | +100.0% | 1.30% | – |
| MSON | Buy | MISONIX INCequity | $4,370,000 | +133.3% | 322,041 | +62.0% | 1.22% | +71.7% |
| TEVA | New | TEVA PHARMACEUTICAL-SP ADRdepository receipt | $3,083,000 | – | 250,000 | +100.0% | 0.86% | – |
| NTRA | New | NATERA INCequity | $2,992,000 | – | 60,000 | +100.0% | 0.83% | – |
| New | TEVA US 09/18/20 C10call | $1,625,000 | – | 6,500 | +100.0% | 0.45% | – | |
| New | SPY US 07/17/20 P290put | $896,000 | – | 4,000 | +100.0% | 0.25% | – | |
| New | XBI US 07/17/20 P105put | $274,000 | – | 2,000 | +100.0% | 0.08% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-08-11
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VERADIGM ORD | 32 | Q3 2023 | 13.9% |
| STREAMLINE HEALTH SOLUTIONS ORD | 30 | Q3 2023 | 4.0% |
| ATRICURE ORD | 29 | Q3 2023 | 7.6% |
| PACIRA PHARMACEUTICALS INC | 27 | Q1 2023 | 12.1% |
| LANTHEUS HOLDINGS ORD | 25 | Q4 2022 | 9.6% |
| MEDTRONIC PLC | 21 | Q1 2022 | 12.7% |
| RIGEL PHARMACEUTICALS ORD | 21 | Q2 2023 | 8.0% |
| BIO RAD LABORATORIES CL A ORD | 19 | Q2 2023 | 10.0% |
| HOLOGIC INC | 17 | Q1 2022 | 6.5% |
| SPY US 10/21/16 P210 | 17 | Q3 2023 | 41.5% |
View Tamarack Advisers, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| STREAMLINE HEALTH SOLUTIONS INC. | June 22, 2023 | 5,514,515 | 9.4% |
| IVERIC bio, Inc. | February 16, 2021 | 850,000 | 0.1% |
| Correvio Pharma Corp. | February 14, 2020 | 2,500,000 | 4.9% |
| OBALON THERAPEUTICS INC | February 14, 2020 | ? | ? |
| Correvio Pharma Corp. | February 15, 2019 | ? | ? |
| Corium International, Inc. | February 15, 2017 | 737,242 | 3.3% |
| ENDOLOGIX INC /DE/Sold out | February 15, 2017 | 0 | 0.0% |
| Imprivata IncSold out | February 15, 2017 | 0 | 0.0% |
View Tamarack Advisers, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-09 |
| 13F-HR | 2023-11-16 |
| 13F-HR | 2023-08-10 |
| SC 13D/A | 2023-06-22 |
| 13F-HR | 2023-05-11 |
| 13F-HR | 2023-02-13 |
| SC 13D/A | 2022-12-01 |
| 13F-HR | 2022-11-15 |
| 13F-HR | 2022-08-16 |
| 13F-HR | 2022-05-11 |
View Tamarack Advisers, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.